View in EDS HTML Full Text PDF Full Text

Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.

Saved in:
Bibliographic Details
Title: Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Authors: Michael M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org., Liauw W; Department of Medical Oncology, St. George's Hospital, Sydney, Australia., McLachlan SA; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia., Link E; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia., Matera A; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia., Thompson M; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Jefford M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia., Hicks RJ; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Cullinane C; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Hatzimihalis A; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Campbell IG; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Rowley S; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Beale PJ; Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Karapetis CS; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia., Price T; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia., Burge ME; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Jul; Vol. 88 (1), pp. 39-52. Date of Electronic Publication: 2021 Mar 23.
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33755789
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Michael+M%22">Michael M</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org.<br /><searchLink fieldCode="AU" term="%22Liauw+W%22">Liauw W</searchLink>; Department of Medical Oncology, St. George's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22McLachlan+SA%22">McLachlan SA</searchLink>; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Link+E%22">Link E</searchLink>; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Matera+A%22">Matera A</searchLink>; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+M%22">Thompson M</searchLink>; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Jefford+M%22">Jefford M</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Hicks+RJ%22">Hicks RJ</searchLink>; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Cullinane+C%22">Cullinane C</searchLink>; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Hatzimihalis+A%22">Hatzimihalis A</searchLink>; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Campbell+IG%22">Campbell IG</searchLink>; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Rowley+S%22">Rowley S</searchLink>; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Beale+PJ%22">Beale PJ</searchLink>; Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Karapetis+CS%22">Karapetis CS</searchLink>; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Price+T%22">Price T</searchLink>; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Burge+ME%22">Burge ME</searchLink>; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2021 Jul; Vol. 88 (1), pp. 39-52. <i>Date of Electronic Publication: </i>2021 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33755789
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-021-04264-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 39
    Titles:
      – TitleFull: Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Michael M
      – PersonEntity:
          Name:
            NameFull: Liauw W
      – PersonEntity:
          Name:
            NameFull: McLachlan SA
      – PersonEntity:
          Name:
            NameFull: Link E
      – PersonEntity:
          Name:
            NameFull: Matera A
      – PersonEntity:
          Name:
            NameFull: Thompson M
      – PersonEntity:
          Name:
            NameFull: Jefford M
      – PersonEntity:
          Name:
            NameFull: Hicks RJ
      – PersonEntity:
          Name:
            NameFull: Cullinane C
      – PersonEntity:
          Name:
            NameFull: Hatzimihalis A
      – PersonEntity:
          Name:
            NameFull: Campbell IG
      – PersonEntity:
          Name:
            NameFull: Rowley S
      – PersonEntity:
          Name:
            NameFull: Beale PJ
      – PersonEntity:
          Name:
            NameFull: Karapetis CS
      – PersonEntity:
          Name:
            NameFull: Price T
      – PersonEntity:
          Name:
            NameFull: Burge ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 88
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1